RT Journal Article
SR Electronic
T1 Protein Classifier for Thyroid Nodules Learned from Rapidly Acquired Proteotypes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.09.20059741
DO 10.1101/2020.04.09.20059741
A1 Yaoting Sun
A1 Sathiyamoorthy Selvarajan
A1 Zelin Zang
A1 Wei Liu
A1 Yi Zhu
A1 Hao Zhang
A1 Hao Chen
A1 Xue Cai
A1 Huanhuan Gao
A1 Zhicheng Wu
A1 Lirong Chen
A1 Xiaodong Teng
A1 Yongfu Zhao
A1 Sangeeta Mantoo
A1 Tony Kiat-Hon Lim
A1 Bhuvaneswari Hariraman
A1 Serene Yeow
A1 Syed Muhammad Fahmy bin Syed Abdillah
A1 Sze Sing Lee
A1 Guan Ruan
A1 Qiushi Zhang
A1 Tiansheng Zhu
A1 Weibin Wang
A1 Guangzhi Wang
A1 Junhong Xiao
A1 Yi He
A1 Zhihong Wang
A1 Wei Sun
A1 Yuan Qin
A1 Qi Xiao
A1 Xu Zheng
A1 Linyan Wang
A1 Xi Zheng
A1 Kailun Xu
A1 Yingkuan Shao
A1 Kexin Liu
A1 Shu Zheng
A1 Ruedi Aebersold
A1 Stan Z. Li
A1 Oi Lian Kon
A1 N. Gopalakrishna Iyer
A1 Tiannan Guo
YR 2020
UL http://medrxiv.org/content/early/2020/04/16/2020.04.09.20059741.abstract
AB Up to 30% of thyroid nodules cannot be accurately classified as benign or malignant by cytopathology. Diagnostic accuracy can be improved by nucleic acid-based testing, yet a sizeable number of diagnostic thyroidectomies remains unavoidable. In order to develop a protein classifier for thyroid nodules, we analyzed the quantitative proteomes of 1,725 retrospective thyroid tissue samples from 578 patients using pressure-cycling technology and data-independent acquisition mass spectrometry. With artificial neural networks, a classifier of 14 proteins achieved over 93% accuracy in classifying malignant thyroid nodules. This classifier was validated in retrospective samples of 271 patients (91% accuracy), and prospective samples of 62 patients (88% accuracy) from four independent centers. These rapidly acquired proteotypes and artificial neural networks supported the establishment of an effective protein classifier for classifying thyroid nodules.Competing Interest StatementThe research group of T.G. is supported by Pressure Biosciences Inc, which provides sample preparation instrumentation.Funding StatementThis work was supported by grants from National Natural Science Foundation of China (81972492) and National Natural Science Fund for Young Scholars (21904107), Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars (LR19C050001), Hangzhou Agriculture and Society Advancement Program (20190101A04). Further support for this project was obtained from the National Cancer Centre Research Fund (Peter Fu Program) and National Medical Research Council Clinician-Scientist Award (NMRC/CSAINV/011/2016), both in Singapore. The prospective study was supported by National Natural Science Foundation of China (81902726), China Postdoctoral Science Foundation (NO. 2018M641739), Natural Science Foundation of Liaoning Province (20180530090).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the manuscript or the supplementary material. MS raw data were deposited in iProX (IPX000444000). All the data will be publicly released upon publication.